Skip to main content
OpenTrials

Clinical trial condition

Carbohydrate Metabolism, Inborn Errors

Explore clinical trials studying Carbohydrate Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

544 public trials 96 recruiting studies
Refine in advanced search Browse all conditions

Carbohydrate Metabolism, Inborn Errors trial results

Completed

Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia

NCT05879224

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +18 more
Locations
  • Puskesmas Hanura Hanura, Lampung, Indonesia
  • Puskesmas Tanjung Leidong Labuhanbatu, North Sumatra, Indonesia
  • Puskesmas Bhintuka Mimika, Special Region of Papua, Indonesia
  • Puskesmas Pasar Sentral Mimika, Special Region of Papua, Indonesia
View Trial Details
Completed

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

NCT05218655

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +36 more
Locations
  • University of California, San Diego Altman Clinical and Translational Research Institute La Jolla, California, United States
  • Stanford University Stanford, California, United States
  • Yale Medicine New Haven, Connecticut, United States
  • Children's National Washington D.C., District of Columbia, United States
View all 26 locations
View Trial Details
Completed

Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®

NCT04759885

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • Centre Hospitalier Henri Duffaut Avignon, France
  • Hospices civils de Lyon Lyon, France
  • Hôpital Edouard Herriot Lyon, France
  • Centre Hospitalier Universitaire de Montpellier Montpellier, France
View all 35 locations
View Trial Details
Completed

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

NCT02675465

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Neuromuscular Research Centre Phoenix, Arizona, United States
  • University of California Irvine Orange, California, United States
  • University of Florida Gainesville, Florida, United States
  • Emory University Division of Medical Genetics Decatur, Georgia, United States
View all 19 locations
View Trial Details
Completed

Study of Infigratinib in Children With Achondroplasia

NCT04265651

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Nemours Alfred I. Dupont Hospital for Children Wilmington, Delaware, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View all 19 locations
View Trial Details

Related conditions